کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
2703794 | 1565134 | 2016 | 4 صفحه PDF | دانلود رایگان |
عنوان انگلیسی مقاله ISI
Intravitreal ranibizumab in the treatment of choroidal neovascularization secondary to morning glory syndrome in a child
ترجمه فارسی عنوان
ranibizumab داخل در درمان نورگ زایی مشیمیه ناشی از سندرم شکوه صبح در یک کودک
دانلود مقاله + سفارش ترجمه
دانلود مقاله ISI انگلیسی
رایگان برای ایرانیان
کلمات کلیدی
موضوعات مرتبط
علوم پزشکی و سلامت
پزشکی و دندانپزشکی
چشم پزشکی
چکیده انگلیسی
Congenital optic nerve abnormalities may rarely cause choroidal neovascularization (CNV). This case report summarizes the clinical and therapeutic outcomes of a 7-year-old boy with unilateral CNV secondary to morning glory syndrome associated with acute visual acuity loss. The patient was successfully treated with a single intravitreal ranibizumab injection. One month after the injection the visual acuity increased and optic coherence tomography (OCT) showed a decrease in the intraretinal fluid around the CNV. The patient was then called for monthly follow-up visits. No further treatment was needed for the next 12 months after the first treatment. There was no complication related to the injection.
ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Saudi Journal of Ophthalmology - Volume 30, Issue 2, April–June 2016, Pages 140–143
Journal: Saudi Journal of Ophthalmology - Volume 30, Issue 2, April–June 2016, Pages 140–143
نویسندگان
Abdullah Özkaya, Ihsan Yilmaz, Zeynep Alkin, Yalcin Karakucuk, Ahmet Taylan Yazici,